Thesis (Ph.D.)--University of Washington, 2019Human induced pluripotent stem cells (hiPSCs) offer tremendous potential for use in engineering human tissues for disease modeling, drug development, and cell therapy. However, differentiated cardiomyocytes are phenotypically immature, reducing assay reliability when translating in vitro results to clinical studies and precluding hiPSC-derived cardiac tissues from therapeutic use in vivo. To address this, we have developed hybrid hydrogels comprised of decellularized myocardial extracellular matrix (dECM) and reduced graphene oxide (rGO) to provide a more instructive microenvironment for proper cellular and tissue development. A tissue-specific protein profile was preserved post-decellularizatio...
Access to robust and information-rich human cardiac tissue models would accelerate drug-based strate...
This work focuses on engineering 3 dimensional (3D) fibrous hybrid scaffolds with human induced plur...
Thesis (M.A.)--Boston UniversityCardiovascular disease is the leading cause of mortality in the worl...
Summary: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise f...
Biomaterials currently used in cardiac tissue engineering have certain limitations, such as lack of ...
While cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represent a promising popu...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
Cardiac tissue engineering provides unique opportunities for cardiovascular disease modeling, drug t...
Author ManuscriptThe application of tissue-engineering approaches to human induced pluripotent stem ...
Cardiovascular disease (CVD) is broadly characterized by a loss of global function, exacerbated by a...
Thesis (Master's)--University of Washington, 2015Cardiac tissue engineering is a promising approach ...
The basic requirement of any engineered scaffold is to mimic the native tissue extracellular matrix ...
Myocardial microenvironment plays a decisive role in guiding the function and fate of cardiomyocytes...
Access to robust and information-rich human cardiac tissue models would accelerate drug-based strate...
Cardiac failure following myocardial infarction is an important global health issue and a leading ca...
Access to robust and information-rich human cardiac tissue models would accelerate drug-based strate...
This work focuses on engineering 3 dimensional (3D) fibrous hybrid scaffolds with human induced plur...
Thesis (M.A.)--Boston UniversityCardiovascular disease is the leading cause of mortality in the worl...
Summary: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise f...
Biomaterials currently used in cardiac tissue engineering have certain limitations, such as lack of ...
While cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represent a promising popu...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
Cardiac tissue engineering provides unique opportunities for cardiovascular disease modeling, drug t...
Author ManuscriptThe application of tissue-engineering approaches to human induced pluripotent stem ...
Cardiovascular disease (CVD) is broadly characterized by a loss of global function, exacerbated by a...
Thesis (Master's)--University of Washington, 2015Cardiac tissue engineering is a promising approach ...
The basic requirement of any engineered scaffold is to mimic the native tissue extracellular matrix ...
Myocardial microenvironment plays a decisive role in guiding the function and fate of cardiomyocytes...
Access to robust and information-rich human cardiac tissue models would accelerate drug-based strate...
Cardiac failure following myocardial infarction is an important global health issue and a leading ca...
Access to robust and information-rich human cardiac tissue models would accelerate drug-based strate...
This work focuses on engineering 3 dimensional (3D) fibrous hybrid scaffolds with human induced plur...
Thesis (M.A.)--Boston UniversityCardiovascular disease is the leading cause of mortality in the worl...